Journal
BRITISH JOURNAL OF HAEMATOLOGY
Volume 139, Issue 4, Pages 519-531Publisher
WILEY
DOI: 10.1111/j.1365-2141.2007.06812.x
Keywords
transplant; prognosis; diagnosis; mould; Candida
Categories
Funding
- NIAID NIH HHS [AI067710, AI054736, AI051468] Funding Source: Medline
Ask authors/readers for more resources
Invasive fungal infections (IFIs) continue to cause considerable morbidity and mortality in haematopoietic stem cell transplant (HSCT) recipients. This review focuses on the risks for, and diagnosis of, IFIs (candidiasis, aspergillosis and other mould infections), and factors that affect current outcomes. Diagnosis of IFI is difficult, with the sensitivity of the gold standard tests (culture and histopathology) often < 50%. Therefore, physicians rely on a constellation of clinical signs, radiography, culture, histopathology and adjunctive tests to establish diagnosis. HSCT recipients often have multiple co-morbidities, and understanding the current outcomes and prognostic variables is therefore important for overall management. This paper reviews historical trends and current data.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available